Felipe Slebe
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 5
- Cancer Cells and Metastasis 3
- Cancer Immunotherapy and Biomarkers 2
-
- Glycogen Storage Diseases and Myoclonus 2
- Co-authors
- Joan J. Guinovart (4 shared papers)Mar Garcı́a-Rocha (3 shared papers)Giorgia Testoni (2 shared papers)Jordi Durán (2 shared papers)Francisco Vilaplana (1 shared paper)Marta Vilaseca (1 shared paper)Pura Muñoz‐Cánoves (1 shared paper)David Sebastián (1 shared paper)
- Journals
- Diabetologia (1 paper)Nature Cancer (1 paper)Cell stem cell (1 paper)Future Oncology (1 paper)Cell Metabolism (1 paper)
- Partner nations
- SpainAustriaUnited Kingdom
In The Last Decade
Felipe Slebe
11 papers receiving 516 citations
Felipe Slebe's Hit Papers
Peers
Comparison fields: 5 of 72
- Cancer Research 103
- Oncology 179
- Rheumatology 46
- Aging 5
- Molecular Biology 191
Countries citing papers authored by Felipe Slebe
This map shows the geographic impact of Felipe Slebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Slebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Slebe more than expected).
Fields of papers citing papers by Felipe Slebe
This network shows the impact of papers produced by Felipe Slebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Slebe. The network helps show where Felipe Slebe may publish in the future.
Co-authors
The 25 scholars most cited alongside Felipe Slebe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells Hit paper breakdown → | 2022 | 172 |
| 2 | 2022 | 95 | |
| 3 | 2017 | 72 | |
| 4 | 2020 | 72 | |
| 5 | 2016 | 51 | |
| 6 | 2014 | 19 | |
| 7 | 2016 | 13 | |
| 8 | 2024 | 10 | |
| 9 | 2016 | 6 | |
| 10 | 2025 | 5 | |
| 11 | 2025 | 3 |
About Felipe Slebe
Felipe Slebe is a scholar working on Oncology, Rheumatology, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 11 papers that have together received 518 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Glycogen Storage Diseases and Myoclonus (2 papers), RNA modifications and cancer (2 papers), Brain Metastases and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Pancreatic function and diabetes (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper) and Lipid metabolism and biosynthesis (1 paper). The work is most often cited by research in Cancer Research (103 citations), Oncology (179 citations), Rheumatology (46 citations), Aging (5 citations) and Molecular Biology (191 citations). Felipe Slebe has collaborated with scholars based in Spain, Austria and United Kingdom. Frequent co-authors include Joan J. Guinovart, Mar Garcı́a-Rocha, Giorgia Testoni, Jordi Durán, Francisco Vilaplana, Marta Vilaseca, Pura Muñoz‐Cánoves, David Sebastián, Iliana López‐Soldado and Mitchell Anthony Sullivan. Their work appears in journals such as Diabetologia, Nature Cancer, Cell stem cell, Future Oncology and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.